Skip to main content

Table 1 Clinical characteristics of the patients and healthy control

From: RETRACTED ARTICLE: Downregulation of miR-483-5p decreases hypoxia-induced injury in human cardiomyocytes by targeting MAPK3

Variables AMI (n = 20) Control (n = 20)
Age (mean ± SD) 65.3 ± 7.4 70.4 ± 8.2
Gender (male/female) 13/7 9/11
CK-MB (ng/mL) 38.95 ± 1.35 18.23 ± 3.64
cTnI (ng/mL) 1.35 ± 1.24 0.08 ± 0.02
HDL (mmol/L) 1.16 ± 1.03 1.32 ± 0.28
LDL (mmol/L) 2.71 ± 0.97 2.64 ± 0.84
TC (mmol/L) 4.27 ± 0.34 3.57 ± 0.75
TG (mmol/L) 1.72 ± 0.65 1.46 ± 0.42
Medical history
 Hypertension (n, %) 14 (70%) 13 (65%)
 Diabetes mellitus (n, %) 8 (40%) 6 (30%)
 Hypercholesterolemia (n, %) 9 (45%) 8 (40%)
 Arrhythmia (n, %) 2 (10%) 3 (15%)
Blood pressure
 Systolic blood pressure (mmHg) 124 ± 16 130 ± 18
 Diastolic blood pressure (mmHg) 81 ± 9 78 ± 12
  1. CK-MB creatine kinase MB isoform, cTnI cardiac troponin I, TC total cholesterol, TG total glyceride, HDL high-density lipoprotein, LDL low-density lipoprotein